

| Catalog No. | HV520053 | ||||
|---|---|---|---|---|---|
| Description |
Anti-Human CPB2/TAFI Nanobody (11A4) [11A4] (HV520053) is a alpaca monoclonal antibody detecting TAFI in ELISA. Suitable for Human.
|
||||
| Species reactivity | Human | ||||
| Applications | ELISA | ||||
| Host species | Alpaca | ||||
| Isotype | VHH-8His-Cys-tag | ||||
| Clone ID | 11A4 | ||||
| Clonality | Monoclonal | ||||
| Target | TAFI, Plasma carboxypeptidase B, Thrombin-activable fibrinolysis inhibitor, CPU, Carboxypeptidase B2, Carboxypeptidase U, pCPB, CPB2 | ||||
| Endotoxin level | Please contact with the lab for this information. | ||||
| Purity | >95% as determined by SDS-PAGE. | ||||
| Purification | Purified by Nickel column. | ||||
| Accession | Q96IY4 | ||||
| Form | Liquid | ||||
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||
| Product Usage Information |
| ||||
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||
| Background | Carboxypeptidase B2 (CPB2/TAFI) is a ~48 kDa protein. Cleaves C-terminal arginine or lysine residues from biologically active peptides such as kinins or anaphylatoxins in the circulation thereby regulating their activities. Down-regulates fibrinolysis by removing C-terminal lysine residues from fibrin that has already been partially degraded by plasmin. | ||||
| Note | For research use only. |

SDS-PAGE for Anti-Human CPB2/TAFI Nanobody (11A4)




Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com


+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский